What Researchers Did
Researchers investigated whether combining the drug alogliptin with motor imagery and hyperbaric oxygen therapy could improve outcomes for 100 patients with diabetic nephropathy and silent cerebral infarction over six months.
What They Found
Patients receiving the combined treatment (Group B) showed significantly lower neurofunctional defects, GPVI mRNA expression, and 11-DH-TXB2 levels compared to those receiving only alogliptin (Group A) (P<0.05). Group B also had higher overall MoCA scores, with significant improvements in visuospatial/executive function, attention, and concentration subscores (P<0.05). Thromboelastogram indexes improved in both groups, but more significantly in Group B, suggesting better thrombolysis absorption and brain damage restoration.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study involved a relatively small number of participants and did not specify the exact hyperbaric oxygen therapy protocol, such as pressure or duration.